DOI: 10.36347/sjams.2019.v07i11.047

Pages: 3714-3717

Melasma is one of the most common acquired and distressing pigmentary skin disorder characterised by symmetrical hyperpigmentation of sun exposed areas of face. Plethora of treatment options available in market including various topical, oral and laser therapy with unsatisfactory results and recurrence. Tranexamic Acid, an antifibrinolytic drug, is now gaining popularity as a depigmenting agent. We have done this study to evaluate the effect of tranexamic acid microinjection in two groups of melasma patients at two different concentrations and frequency of injection and access the response in respective group.